Loading...

Penumbra, Inc.

PEN•NYSE
Healthcare
Medical - Devices
$264.17
$-0.57(-0.22%)

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 76.1/100

Key Financials

Market Cap10.3B
P/E Ratio69.76
EPS (TTM)$3.79
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Week$245.80
1 Month$243.49
3 Months$290.70
1 Year Target$241.30

PEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Penumbra, Inc. (PEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $241.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 69.76 and a market capitalization of 10.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.45%
5-Day Change
2.02%
1-Month Change
4.46%
3-Month Change
7.22%
6-Month Change
39.53%
Year-to-Date (YTD) Change
11.97%
1-Year Change
21.53%
3-Year Change
34.09%
5-Year Change
68.41%
All-Time (Max) Change
550.63%

Contact Information

https://www.penumbrainc.com
510 748 3200
One Penumbra Place, Alameda, CA, 94502

Company Facts

4,500 Employees
IPO DateSep 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions

;